Moleculin Biotech Stock (NASDAQ: MBRX) stock price, news, charts, stock research, profile.
Open | $4.590 |
Close | - |
Volume / Avg. | 7.747K / 33.861K |
Day Range | 4.400 - 4.660 |
52 Wk Range | 4.280 - 24.750 |
Market Cap | $10.233M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 2.09% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Moleculin Biotech (NASDAQ: MBRX) through any online brokerage.
Other companies in Moleculin Biotech’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR) and Coeptis Therapeutics (NASDAQ:COEP).
The latest price target for Moleculin Biotech (NASDAQ: MBRX) was reported by Roth MKM on Friday, April 12, 2024. The analyst firm set a price target for 40.00 expecting MBRX to rise to within 12 months (a possible 770.74% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Moleculin Biotech (NASDAQ: MBRX) is $4.5938 last updated Today at April 19, 2024 at 3:31 PM EDT.
There are no upcoming dividends for Moleculin Biotech.
Moleculin Biotech’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Moleculin Biotech.
Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.